Literature DB >> 17590958

Inhibition of beta-amyloid aggregation and neurotoxicity by complementary (antisense) peptides.

Jonathan R Heal1, Gareth W Roberts, Gary Christie, Andrew D Miller.   

Abstract

Complementary peptides are coded for by the nucleotide sequence (read 5'-->3') of the complementary strand of DNA. By reading the sequence of complementary DNA in the 3'-->5' direction, alternative complementary peptides may be derived. We describe the derivation, testing and analysis of six complementary peptides designed against beta-amyloid peptide 1-40 (Abeta, 40). Data is presented to show that one peptide, designated 3' -->5' betaCP1-15, binds specifically to Abeta 1-40, and inhibits both fibrilisation and neurotoxicity in vitro. This suggests that complementary peptides could be useful leads for drug discovery, especially where diseases of protein misfolding are concerned.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 17590958     DOI: 10.1002/1439-7633(20020104)3:1<86::AID-CBIC86>3.0.CO;2-L

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  4 in total

1.  Molecular Recognition Theory of the complementary (antisense) peptide interactions.

Authors:  Nikola Stambuk; Pasko Konjevoda; Alenka Boban-Blagaić; Biserka Pokrić
Journal:  Theory Biosci       Date:  2005-04       Impact factor: 1.919

2.  The Proteomic Code: a molecular recognition code for proteins.

Authors:  Jan C Biro
Journal:  Theor Biol Med Model       Date:  2007-11-13       Impact factor: 2.432

3.  A simple three-step method for design and affinity testing of new antisense peptides: an example of erythropoietin.

Authors:  Nikola Štambuk; Zoran Manojlović; Petra Turčić; Roko Martinić; Paško Konjevoda; Tin Weitner; Piotr Wardega; Mario Gabričević
Journal:  Int J Mol Sci       Date:  2014-05-26       Impact factor: 5.923

4.  Interaction of α-melanocortin and its pentapeptide antisense LVKAT: effects on hepatoprotection in male CBA mice.

Authors:  Karlo Houra; Petra Turčić; Mario Gabričević; Tin Weitner; Paško Konjevoda; Nikola Stambuk
Journal:  Molecules       Date:  2011-08-26       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.